Clinical Trial Update: Suvorexant for Opioid/Stimulant Co-use [Phase 2]

View source ↗

Summary

Phase 2 trial of suvorexant for co-use of opioids and stimulants has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Stimulant Use Disorder

Drugs mentioned

• Belsomra (suvorexant)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Use Disorder, Stimulant Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-12-23